Table 1:

Demographic data and ocular manifestations of enrolled cases.^*

Patients (No)	47
Eyes (No)	92
Age (years, mean±SD)	48.0±18.0
Follow up (months, mean±SD)	78.6±42.2
Gender (No. (%))
Male	16 (34.1)
Female	31 (65.9)
Race (No. (%))
African-American	10 (21.3)
White	29 (61.7)
Hispanic	2 (4.2)
Other	6 (12.8)
Aniridia-Associated Keratopathy Stage at First Visit (Eye No. (%))
Stage I	12 (13)
Stage II	33 (35.9)
Stage III	25 (27.2)
Stage IV	17 (18.5)
Stage V	5 (5.4)
Non-Corneal Pathologies Recorded during Follow up (Eye No. (%))
Aniridia Fibrosis Syndrome	5 (5.4)
Glaucoma	58 (63)
Angle Closure Glaucoma	2 (2.2)
Ocular Hypertension	3 (3.3)
Uncontrolled Glaucoma (Vision Loss owing to Glaucoma)	1 (1.7)
Cataract	58 (54.3)
Subluxation of the Lens	2 (2.2)
Central Retinal Vein Occlusion	1 (1.1)
Proliferative Vitreoretinopathy	1 (1.1)
Diabetic Retinopathy	1 (1.1)
Vitreous Hemorrhage	1 (1.1)

^*Data are presented as mean±SD, and/or Number (percentage).